Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

54.6K
Overview
54.6K
Vaccines01:21

Vaccines

59
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
59
Immunological Memory01:23

Immunological Memory

18.0K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
18.0K
Diphtheria01:28

Diphtheria

141
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
141
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

67
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
67
Development of Immunocompetence01:22

Development of Immunocompetence

1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indirect Effects in Health Economic Models of Vaccines: Should We Include Them, and How Do We Model Them?

Applied health economics and health policy·2026
Same author

Higher stability of novel live-attenuated oral poliovirus type 2 (nOPV2) despite the emergence of a neurovirulent double recombinant strain in Uganda.

Nature microbiology·2026
Same author

Historical and current spatiotemporal patterns of wild and vaccine-derived poliovirus spread.

Nature microbiology·2025
Same author

Safety, tolerability, and immunogenicity of an adult-specific pneumococcal conjugate vaccine, V116, in people living with HIV (STRIDE-7): a two-part, parallel-group, randomised, active comparator-controlled, international, phase 3 trial.

The lancet. HIV·2025
Same author

Intestinal Mucosal Immune Responses to Novel Oral Poliovirus Vaccine Type 2 in Healthy Newborns.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial.

The Lancet. Infectious diseases·2025

Related Experiment Video

Updated: Apr 15, 2026

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

16.0K

Polio vaccination: past, present and future.

Ananda S Bandyopadhyay, Julie Garon1, Katherine Seib1

  • 12Division of Infectious Diseases, Emory University School of Medicine, 1462 Clifton Road, Room 446, Atlanta, GA 30322, USA.

Future Microbiology
|April 1, 2015
PubMed
Summary

Live attenuated oral polio vaccine (OPV) and inactivated polio vaccine (IPV) are crucial for polio eradication. Research continues to address knowledge gaps for IPV

Keywords:
disease eradicationinactivated polio vaccinepolio end gamevaccine technology

More Related Videos

Whole Body Vibration Methods with Survivors of Polio
04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

9.3K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.6K

Related Experiment Videos

Last Updated: Apr 15, 2026

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

16.0K
Whole Body Vibration Methods with Survivors of Polio
04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

9.3K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.6K

Area of Science:

  • Vaccinology
  • Virology
  • Public Health

Background:

  • Oral polio vaccine (OPV) and inactivated polio vaccine (IPV) are key tools for wild poliovirus eradication.
  • OPV carries risks of paralysis and revertant strains, necessitating a switch to IPV post-eradication.

Observation:

  • IPV is intended to replace OPV for sustained polio eradication.
  • Uncertainties exist regarding IPV's capacity to generate intestinal immunity, particularly in regions with high fecal-oral transmission.

Findings:

  • Substantial data support the effectiveness and safety of both OPV and IPV.
  • Ongoing research aims to resolve specific knowledge gaps concerning IPV's role in eradication.

Implications:

  • Future vaccination policies require comprehensive data to ensure successful and maintained polio eradication.
  • Understanding IPV's immunological profile is critical for global health strategies.